Real-world evidence in HTA: an interview with Sreeram Ramagopalan

Written by Sreeram Ramagopalan (F. Hoffmann-La Roche)

In this expert interview, Sreeram Ramagopalan (F. Hoffmann-La Roche, Basel, Switzerland) discusses how real-world data and evidence may be used to help maintain market access to medicines, as well as when hesitancies regarding the use of these data in health technology assessment (HTA) may arise. We are delighted to welcome Sreeram as the newest member of our Expert Panel on The Evidence Base! We are excited to work with and benefit from Sreeram’s expertise to further develop the site and continue bringing you the insightful content you are after. Please could you introduce yourself? I am the Global Head for...

To view this content, please register now for access

It's completely free